Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Prostatic Neoplasms 22Breast Neoplasms 21Polycystic Ovary Syndrome 12Carcinoma, Non-Small-Cell Lung 11Colorectal Neoplasms 10Lung Neoplasms 8Endometrial Neoplasms 7Pancreatic Neoplasms 6Neoplasms 6Glioblastoma 5Rectal Neoplasms 4Melanoma 4Lymphoma, Large B-Cell, Diffuse 4Insulin Resistance 4Adenocarcinoma of Lung 4Adenocarcinoma 4Uterine Cervical Neoplasms 3Leukoplakia, Oral 3Urinary Bladder Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Obesity 2Neoplasm Metastasis 2Liver Neoplasms 2Leukemia, Myeloid, Acute 2Hyperandrogenism 2Esophageal Neoplasms 2Erythroplasia 2Endometrial Hyperplasia 2Diabetes Mellitus 2Colonic Neoplasms 2

Interventions

Tamoxifen 12Specimen Handling 6Anastrozole 6Chemotherapy, Adjuvant 5Radiotherapy 4Letrozole 4afimoxifene 3Mastectomy, Segmental 3Surgical Procedures, Operative 2Simvastatin 2Radiation Dose Hypofractionation 2Radiation 2Fish Oils 2Fatty Acids, Omega-3 24,17 beta-dihydroxy-4-androstene-3-one 2telapristone acetate 1sargramostim 1ruxolitinib 1polyphenon E 1palbociclib 1fezolinetant 1exemestane 1elacestrant 1darolutamide 1bazedoxifene 1acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1abemaciclib 1Zoledronic Acid 1Testosterone 1Tea 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Carcinoma, Intraductal, Noninfiltrating × Metformin × Clear all
NCT05023967 2026-01-05

Metformin and Nightly Fasting in Women With Early Breast Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
120 enrolled
Breast

Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡